“By 2025, an estimated one million people in the UK and Ireland will have dementia.
Our goal is to find ways to detect it before symptoms appear.
We hope to help predict who is at greatest risk of developing dementia, and help deliver new treatments that slow or prevent the disease.”
Please share this post from @brainhealthscot widely with a series of FAQs to help public and patients alike the #fda #Aducanumab approval statement.
Being in the study is not just interesting but also like having regular health checks allowing me to spot and correct any health issues I may have before I have even noticed them. The data collected by the study may also be useful for other studies making my contribution all the more valuable.
Seeing the effect on my parents’ lives of my father’s Alzheimer’s and Vascular Dementia, the opportunity to take part in this research programme was welcomed. Helping the search for answers to why and who might develop dementia, even in a very small way, has been both interesting and rewarding.